Betrecep 5mg (Tofacitinib Tablet) 5mg

Betrecep 5mg (Tofacitinib 5mg tablets) is a prescription medication used for managing certain inflammatory conditions. This 56-tablet pack provides a convenient supply for ongoing treatment plans. Suitable for ambient storage, it offers reliable access to this widely prescribed therapy.

Strength

5mg

Pack Size

56s

Storage

Ambient

Manufacturer / TM Owner

Pfizer Germany

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tofacitinib 5mg tablets are commonly used to help reduce inflammation and immune system activity in conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Patients often ask, 'what is Tofacitinib 5mg used for?' as it targets specific pathways in the immune response. This medication may be prescribed when other treatments haven't provided sufficient relief.

Side Effects

Many patients experience reduced joint pain and swelling after starting Tofacitinib 5mg, which can improve daily mobility and comfort. Some users report gradual improvements in symptoms over several weeks of consistent use. Individual responses may vary based on condition severity and treatment duration.

Precautions & Warnings

Store Betrecep 5mg at room temperature away from moisture and direct light. Keep this medication out of reach of children and pets. Patients should discuss their full medical history with their healthcare provider before starting this treatment. Regular monitoring may be recommended during use.

Avoid Interactions

Tofacitinib 5mg can interact with certain other medications, including some antibiotics, antifungals, and immunosuppressants. Combining with live vaccines or strong CYP3A4 inhibitors may require dose adjustments. Always inform your doctor about all prescription, over-the-counter, and herbal products you're using.

References

Frequently Asked Questions

Tofacitinib 5mg is primarily used for rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Some patients notice improvements within weeks, though full effects may take longer depending on individual response.

Alcohol consumption should be discussed with your healthcare provider as it may affect treatment or increase side effects.

No, Betrecep 5mg contains tofacitinib, which works differently from corticosteroids.

Avoid live vaccines and consult your doctor before starting new medications or supplements.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.